Event Details

Event Details

Event Details

European Huntington's Disease Network EHDN2022 Plenary Meeting

09/16/22 - 09/18/22

Supporting Materials

Synthesis of key results and conclusions of the SIGNAL phase 2 study of pepinemab as a treatment for early HD 2.7 MB

Title

European Huntington's Disease Network EHDN2022 Plenary Meeting

Date / Time

09/16/22 - 09/18/22